搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Daily
3 天
Liver Fibrosis Scores closely Linked to Elevated Heart Failure Risk: Study
Recent research has established that the scores for noninvasive liver fibrosis such as the Fibrosis-4 (FIB-4) score, the ...
39健康 on MSN
25 分钟
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
瘦子也会得脂肪肝?查出脂肪肝怎么办?减少脂肪肝,一定要科学饮食。
6 天
on MSN
‘I had no idea being a social drinker would damage my liver by 31’
At 31 years old, I was told by doctors that if I didn’t stop drinking alcohol, I could die. I was shocked because I didn’t ...
Medpage Today on MSN
10 天
Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH
Patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis who received a novel ...
Daily
5 天
Study Identifies Key Factors Predicting Liver Fibrosis Progression in Type 2 Diabetes with ...
As liver fibrosis can lead to cirrhosis and increase the risk of liver-related complications, understanding factors that ...
FierceBiotech
11 天
Viking pads case for MASH drug with final ph. 2 data showing significant reductions in ...
Patients in the treatment arms received 1 mg, 2.5 mg, 5 mg or 10 mg doses. After 52 weeks of treatment, patients taking the ...
13 天
Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at ...
Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patientsBoth artificial ...
Yahoo Finance
13 天
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024
Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈